getLeronlimab.com
Business Services · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1111 Main St Ste 660, Vancouver, Washing...Phone Number
(360) 980-8524Website
www.getleronlimab.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About getLeronlimab.com
CytoDyn is a biotechnology company focused on developing Leronlimab, a monoclonal antibody therapeutic drug aimed at treating metastatic triple-negative breast cancer (mTNBC) and HIV. The company is currently conducting clinical trials in the United States and Brazil to evaluate the drug's efficacy in treating severe COVID-19 symptoms. Intended clients include patients suffering from mTNBC, HIV, and critically ill COVID-19 patients, as well as healthcare providers seeking innovative treatment options. CytoDyn aims to address unmet medical needs with its promising therapeutic solutions.Explore more
Popular SearchesgetLeronlimab.comCytoDyn IncSIC Code 87,873NAICS Code 54,541Show more
getLeronlimab.com Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is getLeronlimab.com your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if getLeronlimab.com has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once getLeronlimab.com has new funding data
Earning: See what the market has to say on getLeronlimab.com recently announced quarterly report
Click to see if getLeronlimab.com had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when getLeronlimab.com launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at getLeronlimab.com
getLeronlimab.com, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if getLeronlimab.com is spiking on competitors!
Recommended Actions
Find VP level buyers at getLeronlimab.com
Find 2 more new buyers
Compare Similar Companies to getLeronlimab.com
Compare insights from companies similar to getLeronlimab.com, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
getLeronlimab.com is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
getLeronlimab.com is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about getLeronlimab.com.
getLeronlimab.com Tech Stack
A closer look at the technologies used by getLeronlimab.com
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding getLeronlimab.com
Sign Up For FreeTo access detailed company insights
CytoDyn is a biotechnology company focused on developing Leronlimab, a monoclonal antibody therapeutic drug aimed at treating metastatic triple-negative breast cancer (mTNBC) and HIV. The company is currently conducting clinical trials in the United States and Brazil to evaluate the drug's efficacy in treating severe COVID-19 symptoms. Intended cli... Read More
